InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or
the “Company”), a leading national health care service provider,
facilitating outpatient care for durable medical equipment
manufacturers and health care providers, announced today the
Company is set to join the broad-market Russell 3000® Index at the
conclusion of the 2023 Russell indexes annual reconstitution,
effective after the U.S. market opens on June 26, 2023.
Annual Russell indexes reconstitution captures the 4,000 largest
U.S. stocks as of April 28, ranking them by total market
capitalization. Membership in the U.S. all-cap Russell 3000® Index,
which remains in place for one year, means automatic inclusion in
the large-cap Russell 1000® Index or small-cap Russell 2000® Index
as well as the appropriate growth and value style indexes. FTSE
Russell determines membership for its Russell indexes primarily by
objective, market-capitalization rankings and style attributes.
Richard DiIorio, chief executive officer of InfuSystem, said,
“We are excited to be included in the Russell 3000® Index, one of
the most widely cited performance benchmarks. This is another
meaningful milestone for InfuSystem as we continue building on our
positive momentum to drive future growth and deliver long-term
value creation for our loyal shareholders.”
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for
active investment strategies. Approximately $12.1 trillion in
assets are benchmarked against Russell’s U.S. indexes. Russell
indexes are part of FTSE Russell, a leading global index
provider.
For more information on the Russell 3000® Index and the Russell
indexes reconstitution, go to the “Russell Reconstitution” section
on the FTSE Russell website.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading
national health care service provider, facilitating outpatient care
for durable medical equipment manufacturers and health care
providers. INFU services are provided under a two-platform model.
The lead platform is Integrated Therapy Services (“ITS”), providing
the last-mile solution for clinic-to-home healthcare where the
continuing treatment involves complex durable medical equipment and
services. The ITS segment is comprised of Oncology, Pain
Management, Wound Therapy and Lymphedema businesses. The second
platform, Durable Medical Equipment Services (“DME Services”),
supports the ITS platform and leverages strong service orientation
to win incremental business from its direct payer clients. The DME
Services segment is comprised of direct payer rentals, pump and
consumable sales, and biomedical services and repair. Headquartered
in Rochester Hills, Michigan, the Company delivers local,
field-based customer support and also operates Centers of
Excellence in Michigan, Kansas, California, Massachusetts, Texas
and Ontario, Canada.
About FTSE Russell
FTSE Russell is a global index leader that provides innovative
benchmarking, analytics and data solutions for investors worldwide.
FTSE Russell calculates thousands of indexes that measure and
benchmark markets and asset classes in more than 70 countries,
covering 98% of the investable market globally.
FTSE Russell index expertise and products are used extensively
by institutional and retail investors globally. Approximately $20.1
trillion is currently benchmarked to FTSE Russell indexes. For over
30 years, leading asset owners, asset managers, ETF providers and
investment banks have chosen FTSE Russell indexes to benchmark
their investment performance and create ETF’s, structured products
and index-based derivatives.
A core set of universal principles guides FTSE Russell index
design and management: a transparent rules-based methodology is
informed by independent committees of leading market participants.
FTSE Russell is focused on applying the highest industry standards
in index design and governance and embraces the IOSCO Principles.
FTSE Russell is also focused on index innovation and customer
partnerships as it seeks to enhance the breadth, depth and reach of
its offering.
FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com.
Forward-Looking Statements
Certain statements contained in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, such as statements
relating to future actions, our share repurchase program and
capital allocation strategy, business plans, objectives and
prospects, future operating or financial performance and guidance
and expected new business relationships and the terms thereof. The
words “believe,” “may,” “will,” “estimate,” “continue,”
“anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,”
“future,” “likely,” variations of such words, and other similar
expressions, as they relate to the Company, are intended to
identify forward-looking statements. Forward-looking statements are
subject to factors, risks and uncertainties that could cause actual
results to differ materially, including, but not limited to, our
ability to successfully execute on our growth initiatives, our
ability to enter into definitive agreements for new business
relationships on expected terms or at all, the uncertain impact of
the COVID-19 pandemic, our dependence on estimates of collectible
revenue, potential litigation, changes in third-party reimbursement
processes, changes in law, contributions from acquired businesses
or new business lines, products or services and other risk factors
disclosed in the Company’s most recent annual report on Form 10-K
and, to the extent applicable, quarterly reports on Form 10-Q. All
forward-looking statements made in this press release speak only as
of the date hereof. We do not undertake any obligation to update
any forward-looking statements to reflect future events or
circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230621657274/en/
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC
602-889-9700
InfuSystems (AMEX:INFU)
Historical Stock Chart
From Apr 2024 to May 2024
InfuSystems (AMEX:INFU)
Historical Stock Chart
From May 2023 to May 2024